Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. YB
YB logo

YB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Yuanbao Inc (YB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
16.380
1 Day change
-0.73%
52 Week Range
31.000
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Yuanbao Inc (YB) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company's financial performance is impressive, the technical indicators are bearish, and there are no strong positive catalysts or trading signals to suggest immediate upside potential. It is better to hold off on investing until clearer bullish signals emerge.

Technical Analysis

The technical indicators for YB are bearish. The MACD histogram is negative and expanding downward, the RSI is neutral at 36.452, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level of 17.287, with resistance levels at 18.884 and 19.377.

Positive Catalysts

  • The company reported strong financial growth in Q4 2025, with revenue up 32.24% YoY, net income up 72.76% YoY, and EPS up 61.11% YoY. These figures indicate solid business performance and profitability.

Neutral/Negative Catalysts

  • Technical indicators are bearish, and there is no recent news or significant trading trends from hedge funds or insiders to drive positive sentiment. Analysts have rated the stock as Neutral, with no indication of undervaluation.

Financial Performance

In Q4 2025, Yuanbao Inc demonstrated strong financial growth. Revenue increased to $1.175 billion, up 32.24% YoY. Net income rose to $337.38 million, up 72.76% YoY, and EPS increased to 1.16, up 61.11% YoY. Gross margin remained stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Citi initiated coverage with a Neutral rating and a price target of $21.80, suggesting the stock is fairly valued at current levels. There have been no recent upgrades or downgrades.

Wall Street analysts forecast YB stock price to rise
Analyst Rating
0
Wall Street analysts forecast YB stock price to rise
Buy
Hold
Sell
0
Current: 16.500
sliders
Low
0
Averages
0
High
0
0
Current: 16.500
sliders
Low
0
Averages
0
High
0
Citi
Neutral
initiated
$21.80
AI Analysis
2026-02-23
Reason
Citi
Price Target
$21.80
AI Analysis
2026-02-23
initiated
Neutral
Reason
Citi initiated coverage of Yuanbao with a Neutral rating and $21.80 price target. The company is a leading online insurance broker in China focusing on health insurance, the analyst tells investors in a research note. Citi believes the shares are fairly valued at current levels.

People Also Watch